Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,371
Recruiting: 3,969
Ph III recruiting: 536
Growth YoY: +9.5%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,407)

clinicaltrialsPublishedShowing 1,501–1,550 of 2,039 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07152678	Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma(BRIGHT-ESCC)	recruiting	Phase 2	60	National Taiwan University HospitalOTHER	1	Sep 3, 2025	clinicaltrials
NCT06571708	Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)(NeoSTOP-IT)	recruiting	Phase 2	36	Columbia UniversityOTHER